Back
ESC Premium Access

Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation has no impact on recurrences, cardiovascular events and mortality - insights from the german ablation registry

Session: Congress committee e-posters choice in arrhythmias and device therapy
Topic: Catheter Ablation of Arrhythmias
Speaker: Doctor R. Schleberger (Hamburg, DE)
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

Like

About the speaker

Doctor Ruben Schleberger

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)
0 follower

23 more presentations in this session

Left atrial dysfunction still exists in patients who obtain normal left atrial volume after successful ablation of atrial fibrillation.

Speaker: Doctor H. Kawakami (Toon, JP)

Access
Abstract
Slides
Like
Thumbnail

Same day discharge after atrial fibrillation ablation is feasible and safe. Results of a prospective study in 1015 patients

Speaker: Mr M. Viezelis (Odense, DK)

Access
Abstract
Slides
Like
Thumbnail

Benefits of early intervention with catheter ablation in patients with atrial fibrillation

Speaker: Doctor S. Mohanty (Austin, US)

Access
Abstract
Slides
Like
Thumbnail

Cryoballoon ablation of atrial fibrillation in low and medium volume hospitals - experiences of the German REGIONAL registry

Speaker: Doctor J. Michaelsen (Lingen, DE)

Access
Abstract
Slides
Like
Thumbnail

Accuracy comparison of the new and previous Kodex occlusion tool software versions to assess pulmonary vein occlusion in atrial fibrillation cryoablation

Speaker: Doctor M. Polselli (Rome, IT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Congress committee e-posters choice in arrhythmias and device therapy

Speakers: Doctor R. Schleberger, Doctor H. Kawakami, Mr M. Viezelis, Doctor S. Mohanty, Doctor J. Michaelsen...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources